Literature DB >> 21928224

Determinants of bone mineral density in stable kidney transplant recipients.

Alok K Gupta1, Michael Huang, G V Ramesh Prasad.   

Abstract

BACKGROUND: Kidney transplant recipients (KTR) are at increased risk for bone loss. Determinants of bone mineral density (BMD) in an unselected KTR population have not previously been described.
METHODS: We conducted a cross-sectional analysis of 389 stable KTRs undergoing bone mineral densitometry assessment by dual-energy X-ray absorptiometry at the lumbar spine, total hip and femoral neck. Risk factors for osteopenia and osteoporosis were determined by t-tests or ANOVA and chi-square analysis as appropriate. Factors associated with reduced BMD were ascertained using multivariate linear regression.
RESULTS: At the lumbar spine, 247 demonstrated normal BMD, 115 had osteopenia and 27 osteoporosis. Corresponding prevalence rates for the total hip and femoral neck were 222/143/24 and 178/184/27, respectively. Osteopenia or osteoporosis was more prevalent at the femoral neck than lumbar spine (p=0.002). Osteopenia or osteoporosis at the spine, hip and femoral neck were highly correlated (p<0.0001). Independent associations with reduced BMD included female sex (p<0.0001) and lower body mass index (p<0.0001) at all sites, age for total hip and femoral neck (p=0.0001), and hyperparathyroidism (p=0.036), time posttransplant (p=0.0001) for the femoral neck, with no association by renal function or 25-OH vitamin D level at any site.
CONCLUSIONS: Significant bone loss in KTRs is most prevalent at the femoral neck. Identifying risk factors for specific sites may allow for earlier intervention prior to osteoporosis development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21928224     DOI: 10.5301/jn.5000015

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  7 in total

Review 1.  Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.

Authors:  Takashi Hirukawa; Takatoshi Kakuta; Michio Nakamura; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2015-05-02       Impact factor: 2.801

Review 2.  Osteoporosis after renal transplantation.

Authors:  Evangelia Dounousi; Konstantinos Leivaditis; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int Urol Nephrol       Date:  2014-11-11       Impact factor: 2.370

3.  Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.

Authors:  N Segaud; I Legroux; M Hazzan; C Noel; B Cortet
Journal:  Osteoporos Int       Date:  2018-03-02       Impact factor: 4.507

Review 4.  Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.

Authors:  Gong-bin Lan; Xu-biao Xie; Long-kai Peng; Lei Liu; Lei Song; He-long Dai
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

5.  Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients.

Authors:  Chih-Hsien Wang; Jen-Pi Tsai; Yu-Hsien Lai; Yu-Li Lin; Chiu-Huang Kuo; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2016-05-28

6.  Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation.

Authors:  Benjamin Batteux; Sandra Bodeau; Camille André; Anne-Sophie Hurtel-Lemaire; Valérie Gras-Champel; Isabelle Desailly-Henry; Kamel Masmoudi; Youssef Bennis; Ziad A Massy; Saïd Kamel; Gabriel Choukroun; Sophie Liabeuf
Journal:  Toxins (Basel)       Date:  2020-11-13       Impact factor: 4.546

7.  Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting.

Authors:  Benjamin Batteux; Valérie Gras-Champel; Mathilde Lando; François Brazier; Romuald Mentaverri; Isabelle Desailly-Henry; Amayelle Rey; Youssef Bennis; Kamel Masmoudi; Gabriel Choukroun; Sophie Liabeuf
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-10-29       Impact factor: 5.346

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.